amobarbital has been researched along with Cerebral Ischemia in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogolepov, NN | 2 |
| Burd, GS | 2 |
| Rumiantseva, SA | 2 |
| Gusev, EI | 1 |
2 other studies available for amobarbital and Cerebral Ischemia
| Article | Year |
|---|---|
[Status of cerebral capillary circulation during ischemia with barbiturate protection].
Topics: Amobarbital; Animals; Brain Ischemia; Capillaries; Capillary Permeability; Cerebral Cortex; Microsco | 1983 |
[Ultrastructural aspects of acute cerebral ischemia after treatment with barbiturates].
Topics: Amobarbital; Animals; Brain Ischemia; Carotid Artery Diseases; Motor Cortex; Organoids; Rats; Rats, | 1982 |